The Excellent Chemical Interaction Properties of Poloxamer and Pullulan with Alpha Mangostin on Amorphous Solid Dispersion System: Molecular Dynamics Simulation

• Published in: Polymers Vol. 16; no. 21; p. 3065
• Main Authors: Rusdin, Agus, Muchtaridi, Muchtaridi, Megantara, Sandra, Wardhana, Yoga Windhu, Fakih, Taufik Muhammad, Budiman, Arif
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 31-10-2024; MDPI
• Subjects: alpha mangostin; amorphous solid dispersion; Bioavailability; Breast cancer; Cancer; Cancer therapies; Care and treatment; Chemical bonds; Comparative analysis; Cooling; Cooling rate; Dynamic structural analysis; Effectiveness; Hydrogen; Hydrogen bonding; Ligands; molecular dynamic; Molecular dynamics; Molecular structure; Optimization; poloxamer; Poloxamers; Polymers; Polysaccharides; Prostate; Pullulan; Simulation; Simulation methods; Software; Solubility; Stability; Indonesia
• ISSN: 2073-4360; 2073-4360
• DOI: 10.3390/polym16213065

Background: Alpha mangostin (AM) has demonstrated significant potential as an anticancer agent, owing to its potent bioactivity. However, its clinical application is limited by poor solubility, which hampers its bioavailability and effectiveness. Amorphous solid dispersion (ASD) presents a promising technique to enhance the solubility and stability of AM. Molecular dynamics simulation offers a rapid, efficient, and precise method to evaluate and optimize ASD formulations before production. Aim of Study: In this study, we conducted molecular dynamics simulations to explore the ASD development of AM with poloxamer and pullulan. Result: Our results revealed that AM–poloxamer complexes exhibit superior interaction characteristics compared to AM–pullulan, with a 1:5 ratio of AM to poloxamer and a cooling rate of 1 °C/ns demonstrating the most favorable outcomes. This combination showed enhanced hydrogen bonding, a more compact molecular structure, and higher stability, making it the optimal choice for ASD formulation. Conclusion: The integration of molecular dynamics simulation into ASD development significantly accelerates the formulation process and provides critical insights into achieving a stable and effective AM dispersion. The AM–poloxamer complex, particularly at a 1:5 ratio with a 1 °C/ns cooling rate, offers the best potential for improving AM solubility and therapeutic efficacy.